Lander Foquet

10PUBLICATIONS
58CO-AUTHORS
Characterisation of biological macromoleculesMolecular targetsPharmacogenomicsCheminformatics and quantitative structure-activity relationshipsMedical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 02, 2025
Discovery of Potent, Selective and Efficacious Aminopyrazole Inhibitors of PLK4.

Joon Won Jeong, Trevor Chang, Jeremy M Murray

|Nov 06, 2025
Enozertinib Is a Selective, Brain-Penetrant EGFR Inhibitor for Treating Non-Small Cell Lung Cancers with EGFR Exon 20 and Atypical Mutations.

Melissa R Junttila, Claire E Repellin, Sumeet Salaniwal

|Oct 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor Immunosuppression.

Jared T Moore, Hiroyuki Kawai, Brian R Blank

|Jul 31, 2023
Analysis of the Bile Acid Composition in a Fibroblast Growth Factor 19-Expressing Liver-Humanized Mouse Model and Its Use for CYP3A4-Mediated Drug-Drug Interaction Studies.

Mario Mezler, Robert S Jones, Dewakar Sangaraju

|May 31, 2022
Application of empirical scalars to enable early prediction of human hepatic clearance using IVIVE in drug discovery: an evaluation of 173 drugs.

Robert S Jones, Christian Leung, Jae H Chang

|Jul 12, 2021
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer.

Jun Liang, Jason R Zbieg, Robert A Blake

Pageof 2

Frequent Collaborators

2 joint publications

Robert S Jones

2 joint publications

Lori S Friedman

2 joint publications

Brian R Blank

1 joint publications

Shannon D Shields